Reduction of myocardial infarct size by dronedarone in pigs - A pleiotropic action?

Cardiovascular Drugs and Therapy

Volumn 25, Issue 3, 2011, Pages 197-201

  Skyschally, Andreas ^a   Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Dronedarone; Infarct size; Myocardial ischemia; Reperfusion

Indexed keywords

DRONEDARONE; MICROSPHERE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART ATRIUM PACING; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE BLOOD FLOW; HEART PROTECTION; HEART RATE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SWINE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; CALCIUM; CARDIOTONIC AGENTS; CORONARY CIRCULATION; HEART RATE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; SWINE; SWINE, MINIATURE;

EID: 79958279816     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-011-6300-1     Document Type: Article

References (19)

1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429.
2. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;375:1212-23.
3. Watanabe Y, Kimura J. Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes. N Schmied Arch Pharmacol. 2008;377:371-6.
4. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009;360:668-78.
5. Heusch G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol. 2008;153:1589-601. (Pubitemid 351535988)
6. Wichmann J, Ertl G, Hohne W, Schweisfurth H, Wernze H, Kochsiek K. Alpha-receptor restriction of coronary blood flow during atrial fibrillation. Am J Cardiol. 1983;52:887-92. (Pubitemid 13023781)
7. Ertl G, Meesmann M, Krumpiegel K, Kocksiek K. The effects of atrial fibrillation on coronary blood flow and performance of ischaemic myocardium in dogs with coronary artery stenosis. Clin Sci. 1987;73:437-44. (Pubitemid 17119213)
8. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, et al. α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation. 2000;101:689-94. (Pubitemid 30094742)
9. Hodeige D, Heyndrickx JP, Chatelain P, Manning A. SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol. 1995;279:25-32.
10. Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D, L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol. 1995;26:570-6.
11. Hammwöhner M, Bukowska A, Sixdorf A, Röhl F-W, Lendeckel U, Bode-Böger SM, et al. Dronedaron verhindert Störungen der koronaren Mikrozirkulation im linken Ventrikel während atrialer Tachyarrhythmie. Clin Res Cardiol Suppl. 2010;99.
12. Heusch G, Skyschally A, Schulz R. The in-situ pig heart with regional ischemia/reperfusion- ready for translation. J Mol Cell Cardiol. 2011. doi:10.1016/j.yjmcc.2011.02.016.
13. Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, et al. Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial). Am J Cardiol. 2011;107:1019-22.
14. Hausenloy DJ, Baxter G, Bell R, Bøtker HE, Davidson SM, Downey J, et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol. 2010;105:677-86.
15. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res. 2010;87:406-23.
16. 2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res. 2002;55:739-48.
17. Heusch G. Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction. Br J Pharmacol. 2008;155:970-1.
18. Heusch G, Skyschally A, Gres P, van Caster P, Schilawa D, Schulz R. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine - protection beyond heart rate reduction. Eur Heart J. 2008;29:2265-75.
19. 2+ and HCN channels. N Schmied Arch Pharmacol. 2011;383:347-56.